TCGX Acquisition Corp. prices $75M IPO on Nasdaq

TCGX Acquisition Corp. priced its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share, raising $75 million, according to a press release from the company.

The Class A ordinary shares are set to begin trading on the Nasdaq Capital Market under the ticker symbol NASDAQ: TCGX on August 5, 2026, with the offering expected to close on August 6, 2026, subject to customary closing conditions.

The company is a special purpose acquisition company (SPAC) sponsored by TCGX Sponsor, LLC, an affiliate of TCG Crossover Management, LLC. It intends to focus its search for acquisition targets in the healthcare and healthcare-related industries, particularly in the life sciences and medical technology sectors, though it may pursue opportunities in any industry or geography.

Unlike some other SPAC offerings, investors in this offering will not receive warrants exercisable following completion of an initial business combination.

Jefferies is acting as the sole book-running manager. The company has granted the underwriter a 45-day option to purchase up to an additional 1,125,000 Class A ordinary shares at the IPO price to cover over-allotments.

The SEC declared the related registration statement effective on August 4, 2026.

You May Also Be Interested In

• TCGX Acquisition Corp. raises $86.25M in Nasdaq IPO
• Femasys raises $30M in private placement with warrant upside
• PubMatic CFO Steve Pantelick to retire in 2027 after 15 years